The immunoproteasome regulates a PRAME-derived HLA-I tumor antigen that can be targeted therapeutically with a TCR mimic antibody

Explore related products in the following collection:

Poster Abstracts - C717

ePosters - C717

Related Products

Thumbnail for Cathepsin D inhibitors as potential therapeutics for breast cancer treatment against triple-negative and triple-positive breast cancers

Cathepsin D inhibitors as potential therapeutics for breast cancer treatment against triple-negative and triple-positive breast cancers

Thumbnail for Site-specific conjugation of novel flourophores and tags to accelerate immunotherapy discovery and development

Site-specific conjugation of novel flourophores and tags to accelerate immunotherapy discovery and development

Thumbnail for β -Alethine, An Immunostimulatory Drug That Synergizes With Anti-PD1 Therapy

β -Alethine, An Immunostimulatory Drug That Synergizes With Anti-PD1 Therapy

Thumbnail for Promotion of immunogenicity using epigenetic modulation and immune checkpoint inhibition in mouse models of breast cancer

Promotion of immunogenicity using epigenetic modulation and immune checkpoint inhibition in mouse models of breast cancer

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.